A Phase 2a Study of BIIB074 in the Treatment of Erythromelalgia

Clinical trial NCT02917187 · COMPLETED

Trial details

NCT number: NCT02917187
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Inherited Erythromelalgia

Start date: 2016-09-09
Primary completion: 2016-12-27
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.